Colorectal Cancer: Blood Test Screening Options
- Colorectal cancer (CRC) remains a leading cause of cancer deaths in the U.S., despite overall declines in incidence and mortality in recent decades.
- Currently, 42% of Americans between 45 and 75 years old are not up to date with recommended colorectal cancer screening.Evidence strongly supports the effectiveness of lower intestinal endoscopy,...
- Despite public awareness campaigns and organized screening programs, participation rates remain suboptimal.
Despite advancements, the colorectal cancer (CRC) screening gap persists. News Directory 3 highlights that a notable portion of CRC deaths are preventable through screening. However, a concerning 42% of Americans aged 45-75 are not up-to-date with recommended screenings. Explore existing methods, including colonoscopies and stool tests, but understand the pursuit of a more accessible option continues. Accessibility, sensitivity, and non-invasiveness are vital. Current screening methods aim to detect early cancers and precancerous lesions, yet obstacles remain. this piece underscores the critical need for increased screening participation to reduce mortality rates. The ideal colorectal cancer screening test is evolving. Discover what’s next in the quest for more convenient and widely accepted testing options.
Colorectal cancer screening Lag Persists Despite Available Options
Updated July 2, 2025
Colorectal cancer (CRC) remains a leading cause of cancer deaths in the U.S., despite overall declines in incidence and mortality in recent decades. Experts say a important portion of these deaths could be prevented thru increased screening participation.
Currently, 42% of Americans between 45 and 75 years old are not up to date with recommended colorectal cancer screening.Evidence strongly supports the effectiveness of lower intestinal endoscopy, such as colonoscopy or flexible sigmoidoscopy, and repeated stool-based screening tests in detecting early, curable cancers. These methods can also prevent cancer by identifying and removing precancerous lesions.
Despite public awareness campaigns and organized screening programs, participation rates remain suboptimal. This “screening gap” may stem from factors such as inconvenience, discomfort, embarrassment, aversion to handling stool, or fear of complications associated with the procedures. The search continues for a more agreeable and accessible colorectal cancer screening test.
Ideally, a CRC screening test would be noninvasive, highly sensitive for both early cancer and advanced precancerous lesions, have excellent specificity, and be widely accessible. However, current screening options fall short of this ideal in at least one way, limiting their overall effectiveness in the fight against colorectal cancer.
What’s next
Researchers continue to explore new and improved colorectal cancer screening methods to increase participation rates and further reduce mortality from this preventable disease. The focus remains on developing tests that are more convenient,less invasive,and more acceptable to the general population.